Helius Medical Technologies, based in Newtown, Pennsylvania, focuses on neurological wellness and went public on June 27, 2014. Their product, PoNS, is a non-implantable device that treats gait and balance deficits.
HSDT has been in the news recently: Helius Medical Technologies experienced a rise in its HSDT shares following the announcement of an authorized payment claim for the PoNS Device from Aetna Healthcare. Additionally, the company reported a 15% increase in revenue and sales this quarter, indicating strong demand and effective marketing strategies.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
